SCHEMBL167356

SCHEMBL167356

CCCOC(=O)C=CC#N

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.59
ATM Q13315 1/20 0.52
APP P05067 5/20 0.42
ALOX5 P09917 1/20 0.41
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.37
ZDHHC2 Q9UIJ5 1/20 0.37
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21999255 1.00 HCAR2 (0.59) HCAR2ATMAPPALOX5MAPT
Propionic Acid SCHEMBL28030239 0.93 HCAR2 (0.56) HCAR2ATMAPPALOX5MAPT
SCHEMBL4888226 0.89 HCAR2 (0.47) HCAR2ATMAPPALOX5MAPT
SCHEMBL4888287 0.89 HCAR2 (0.47) HCAR2ATMAPPALOX5MAPT
SCHEMBL24797 0.88 ATM (0.70) HCAR2ATMAPPMAPTRAB9A
SCHEMBL1452125 0.86 HCAR2 (0.62) HCAR2ATMAPPMAPTRAB9A
SCHEMBL4892566 0.86 ATM (0.52) HCAR2ATMAPPALOX5MAPT
SCHEMBL29341 0.85 HCAR2 (0.64) HCAR2ATMAPPMAPTRAB9A
SCHEMBL3457992 0.85 HCAR2 (0.64) HCAR2ATMAPPMAPTRAB9A
SCHEMBL15229292 0.85 HCAR2 (0.64) HCAR2ATMAPPMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US claimed
EP-4717744-A1 USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE Bostik SA (FR) 2026-04-01 EP claimed
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE Anthro Energy, Inc. (US) 2026-03-26 US claimed
EP-4127003-B1 HYBRID LIGHT-CURING COMPOSITION DYMAX CORP (US) 2025-11-12 EP claimed
US-20250215132-A1 TWO-PART CURABLE COMPOSITION BOSTIK SA (FR) 2025-07-03 US claimed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP claimed
US-20250149631-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-08 US claimed
WO-2025091014-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-01 WO claimed
CN-116209729-B Thickener for cyanoacrylate-based adhesives 旭化成株式会社 2025-04-08 CN claimed
CN-119455136-A Biodegradable stent, preparation method thereof and biodegradable stent system 上海畅德医疗科技有限公司 2025-02-18 CN claimed
WO-2002053666-A1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS LOCTITE (R & D) LIMITED (IE) 2002-07-11 WO claimed
EP-0963420-A1 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS LOCTITE CORPORATION (US) 1999-12-15 EP claimed
WO-1998038260-A9 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS 1999-02-11 WO claimed
WO-1998038260-A1 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS LOCTITE CORPORATION (US) 1998-09-03 WO claimed
US-5665107-A Surface opening adhesive sealer HEMODYNAMICS, INC. (US) 1997-09-09 US claimed
US-5653730-A Surface opening adhesive sealer HEMODYNAMICS, INC. (US) 1997-08-05 US claimed
US-5529577-A Surface opening adhesive sealer HEMODYNAMICS, INC. (US) 1996-06-25 US claimed
US-5383899-A Method of using a surface opening adhesive sealer HEMODYNAMICS, INC. 1995-01-24 US claimed
US-4425471-A HEAT AND WATER RESISTANT MINNESOTA MINING & MANUFACTURING COMPANY (US) 1984-01-10 US claimed
US-4296185-A SOLVENT DEPOLARIZER, ADHERENT FILM OF CYANOACRYLATE ALTUS CORPORATION 1981-10-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE FTO, DCX, TET1 HCAR2 3507/4885ATM 1912/4885APP 4735/4885
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 HCAR2 3113/4885ATM 614/4885APP 2860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.